As per this study the Global Antiviral Drugs Market was valued USD XXX MN (by revenue) in 2019 and is anticipated to reach USD XXX MN by 2026 with a CAGR of X.X%.
Antiviral drugs are the one which specifically is used to treat viral infectious disease. Unlike antibiotic, antiviral do not kill the target pathogen rather they stop the development of the pathogen. Even there are few listed natural antiviral which is produced by plants, eucalyptus is one of those. Researchers are working on extending the range of antiviral drugs to meet the growing need of the product owing to the rising incidence of viral diseases around the world.
The market of antiviral drugs is growing mainly on the ground of rising prevalence of infectious disease along with the presence of strong pipeline of the product. The rise in competition among the manufacturer for the development of novel drugs is also likely to enhance the market of the antiviral drugs. Also, increasing STD's disease and growing awareness among the people for early and efficient treatment is also projected to raise the demand for the product along with the increasing healthcare expenditure, will boost the growth of the market. However, the high cost of the drugs is likely to restrain the market growth.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of antiviral drugs.
The broad antiviral drugs market has been sub-grouped into mechanism of action, type and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Mechanism of Action
- Nucleotide Polymerase Inhibitors
- Reverse Transcriptase Inhibitors
- Protease Inhibitors
- Herpes Simplex Virus
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for antiviral drugs in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Europe Antiviral Drugs Market By Revenue (USD MN)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the antiviral drugs market includes AbbVie, Aurobindo Pharma, Bristol-Myers-Squibb, Cipla, Dr. Reddy’s Laboratories Ltd, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche AG, Johnson and Johnson, Merck & Co, and Mylan N.V.. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.